Health Economics

At ASCO 2015, Leonard B. Saltz, MD, was given a prominent soapbox from which to voice his concerns about the rising cost of cancer care.
Contrary to the notion that chemotherapy infusion has largely become a hospital-based procedure, analysts from Aetna found that approximately 75% of their patients still receive chemotherapy in a community oncology practice setting.
Leonard B. Saltz, MD, wants the new checkpoint inhibitors to be available to his patients, but he questions how society will pay for them.
It comes as no surprise: targeted therapies now dominate anticancer drug spending in the United States, according to a team of researchers from several major cancer centers.
“Chemotherapy plus bevacizumab costs less and achieves very similar survival and quality-adjusted survival as chemotherapy plus cetuximab for first-line treatment of KRAS wild-type metastatic colorectal cancer,” according to Deborah Schrag, MD, MPH, who presented the analysis at ASCO 2015.
Necitumumab is currently being considered by the US Food and Drug Administration’s (FDA) Oncology Drugs Advisory Committee for the treatment of metastatic squamous-cell lung cancer.
An episode-based payment model cut the cost of breast cancer treatment by 34%, ac­cording to Lee N. Newcomer, MD, MHA
Implementing a clinical pathway for stage IV non–small-cell lung cancer (NSCLC) led to a reduction in chemotherapy drug costs at the Cleveland Clinic, reported James P. Stevenson, MD.
The prevention of common skin cancers and precancers is possible by taking an inexpensive, widely available, oral pill twice daily.
Drug reimbursement decisions should incorporate value and cost-effectiveness, suggested Andreas Laupacis, MD, MSc.... Dr Laupacis has chaired many drug reimbursement committees in Canada
Page 1 of 13
Results 1 - 10 of 121
  •  Association for Value-Based Cancer Care
  • Oncology Practice Management
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Rheumatology Practice Management
  • Urology Practice Management
  • Lynx CME